Vesicant antineoplastic drugs
Drugs classified as “Vesicant” in at least one of the three guidelines. Each guideline column shows the class it assigns.
| ONS/ASCO 2025 | ESMO-EONS 2012 | JSCN/JSMO/JASPO 2024 | |
|---|---|---|---|
| Amrubicin | — | — | Vesicant |
| Bendamustine | Irritant with vesicant properties | Vesicant | — |
| Busulfan | — | — | Vesicant |
| Cisplatin (≥0.5 mg/ml) | Vesicant | — | — |
| Dactinomycin | Vesicant | Vesicant | Vesicant |
| Daunorubicin | Vesicant | Vesicant | Vesicant |
| Docetaxel | Irritant with vesicant properties | Vesicant | Vesicant |
| Doxorubicin | Vesicant | Vesicant | Vesicant |
| Epirubicin | Vesicant | Vesicant | Vesicant |
| Idarubicin | Vesicant | Vesicant | Vesicant |
| Lurbinectedin | Vesicant | — | — |
| Mechlorethamine | — | Vesicant | — |
| Mitomycin C | Vesicant | Vesicant | Vesicant |
| Mitoxantrone | Irritant with vesicant properties | VesicantIrritant | Vesicant |
| Oxaliplatin | Irritant with vesicant properties | Irritant | Vesicant |
| Paclitaxel | Irritant with vesicant properties | Vesicant | Vesicant |
| Ranimustine | — | — | Vesicant |
| Trabectedin | Vesicant | Vesicant | Vesicant |
| Vinblastine | Vesicant | Vesicant | Vesicant |
| Vincristine | Vesicant | Vesicant | Vesicant |
| Vindesine | — | Vesicant | Vesicant |
| Vinorelbine | Vesicant | Vesicant | Vesicant |